| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000003838 |
| Receipt No. | R000004624 |
| Official scientific title of the study | A phase I/II clinical trial of carbon-ion radiotherapy in 12 fractions for prostate cancer |
| Date of disclosure of the study information | 2010/07/01 |
| Last modified on | 2016/11/01 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | A phase I/II clinical trial of carbon-ion radiotherapy in 12 fractions for prostate cancer | |
| Title of the study (Brief title) | 12-fractionation carbon-ion RT for prostate cancer | |
| Region |
|
|
| Condition | |||
| Condition | prostate cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | to assess safety and efficacy of carbon-ion radiotherapy in 12 fractions for prostate cancer |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Phase I,II |
| Assessment | |
| Primary outcomes | incidence of late radiation toxicity |
| Key secondary outcomes | relapse-free survival rate, overall survival rate, cause-specific survival rate, quality of life assessment |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | carbon-ion radiotherapy in 12 fractions | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1)pathologically confirmed prostate cancer
2)T1b,T1c,T2a,T2b,T2c,T3a, or T3b, and M0 in UICC TNM classification in 2009 3)clinically N0 (by imaging) or pathologically N0 or N1 (in 1992 UICC, solitary positive node less than 2cm in diameter) 4)signed consent form |
|||
| Key exclusion criteria | 1)previous radiation therapy for pelvis
2)expected survival period < 6 months 3)Performance status worse than 2 4)previous treatment other than hormonal therapy for prostate cancer 5)concurrent other malignancy 6)active infection in pelvis 7)not inclusive because of other serious medical or psychological problem |
|||
| Target sample size | 45 | |||
| Research contact person | |
| Name of lead principal investigator | Jun Shimazaki |
| Organization | National Institute of Radiological Sciences |
| Division name | Research center for charged particle therapy |
| Address | 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan |
| TEL | 043-206-3350 |
| h_tsuji@nirs.go.jp | |
| Public contact | |
| Name of contact person | Hiroshi Tsuji |
| Organization | National Institute of Radiological Sciences |
| Division name | Research center for charged particle therapy |
| Address | 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan |
| TEL | 043-206-3350 |
| Homepage URL | |
| h_tsuji@nirs.go.jp | |
| Sponsor | |
| Institute | National Institute of Radiological Sciences, Network congress of charged particle therapy |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japanese ministry of education, culture, sports, science and technology |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 放射線医学総合研究所(千葉県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004624 |